Stryker reported strong Q2 organic net sales growth around 10 % and adjusted EPS growth of roughly 11 %, with results including a $175 m estimated hit from tariffs. Full year EPS guidance was raised to $13.40 to $13.60, above consensus of $13.36, while organic sales are forecast to grow 9.5 % to10 % despite tariff headwinds. The company also noted operating margin expansion and improved cost structure via tariff mitigation strategies like reshoring and pricing.